Entospletinib |
Inhibitor of SYK
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
More...
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| SYK |
|
|
Inhibitor
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
Profiled using the KinomeScan platform against a panel of 359 nonmutant kinases at a single conce ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
target protein phosphorylation assay
Selectivity Assessment Description:
In cells, Entospletinib inhibited Flt3, Jak2, c-Kit, KDR, and Ret with 13- to >1000-fold cellu ...
Potency Cellular
In Vitro
SYK
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm500228a
In Vivo Validations
Rat
Dose: 0.4 mg/Kg (IV), 1.0 (PO) mg/Kg
Route of delivery:
Intravenous, Oral
Plasma half life:
35 min
Systemic clearance:
0.27 L/h/kg IV
Fb :
99.2%
Bioavailability:
67 ± 9% PO
Volume of Distribution at Steady-State:
0.52 ± 0.05 L/Kg IV
DOI Reference: 10.1021/jm500228a
Dog
Dose: 0.4 mg/Kg IV, 1.0 mg/Kg PO
Route of delivery:
Intravenous, Oral
Systemic clearance:
0.80 ± 0.03 L/h/Kg IV
Fb :
92.8%
Bioavailability:
53 ± 16% PO
Volume of Distribution at Steady-State:
1.41 ± 0.40 L/Kg IV
DOI Reference: 10.1021/jm500228a
Chemical Information
| Molecular Formula | C23H21N7O |
| SMILEs | c1cn2cc(-c3ccc4cn[nH]c4c3)nc(Nc3ccc(N4CCOCC4)cc3)c2n1 |
| InChI | InChI=1S/C23H21N7O/c1-2-17-14-25-28-20(17)13-16(1)21-15-30-8-7-24-23(30)22(27-21)26-18-3-5-19(6-4-18)29-9-11-31-12-10-29/h1-8,13-15H,9-12H2,(H,25,28)(H,26,27) |
| Molecular weight | 411.18 Da |
| AlogP | 3.852800000000002 |
| HBond acceptors | 8 |
| HBond donors | 2 |
| Atoms | 52 |
| PAINS * | Yes |
* This is an automated alert only, and may not necessarily indicate an issue with this probe. ( Learn more about PAINS )
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the Portal.